The possible involvement of heparanase in this observation is supported by our previous studies showing that heparanase expression is increased substantially in myeloma patients and cells treated with chemotherapy [40], providing a strong rationale for applying anti-heparanase therapy in combination with conventional anti-cancer drugs. The gene discussed is HPSE; the disease is plasma cell myeloma.